Knockdown of matriptase in endometrial cancer cells inhibits migration and invasion ability in vitro [45], and our recent work showed that CRISPR-mediated disruption of KLK5 blocks OSCC cell migration [21]. Here, KLK5 is linked to endometrial cancer.